Last reviewed · How we verify
NCT03293264
Exercise Training on Metabolic Syndrome Severity in Employees
NA trial testing Exercise training group in Metabolic Syndrome in 314 participants. Completed in 8 July 2023.
17 December 2022
Quick facts
| Lead sponsor | Hannover Medical School |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 314 |
| Start date | 17 October 2017 |
| Primary completion | 17 December 2022 |
| Estimated completion | 8 July 2023 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Exercise training group
Conditions studied
- Metabolic Syndrome — all drugs for Metabolic Syndrome →
Sponsor
Hannover Medical School
Who can join
18 and older, any sex, with Metabolic Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Hypothesis: An occupational 6 months physical exercise training will lead to better health behaviour and improve the severity of the metabolic syndrome. 312 subjects will be assigned to either an intervention or a waiting-control-group. The intervention group will receive instructions with the aim to perform 150 min exercise training per week. Exercise consists of endurance, strength and coordination training. A feedback system guided by sports scientists will be installed for all subjects in the intervention group using activity monitoring (wearable). After 6 months training subjects from the intervention group will be assigned to one of the following groups for follow-up observation from month 6 to months 12: * training with personal/individual feedback from sport scientist * training with automated feedback using activity monitoring Tools (wearable) * training without further feedback Subjects assigned to the control group will be provided with information on low intensity motion exercises. After 6 months in the control group subjects will be provided with the same exercise intervention as the intervention for a duration of 6 months. Study visits will be conducted at month 0, month 6, month 12, and a long-term follow-up at month 24..
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Telemonitoring-supported exercise training, metabolic syndrome severity, and work ability in company employees: a randomised controlled trial.
Haufe S, Kerling A, Protte G, Bayerle P, et al · · 2019 · cited 44× · PMID 31204284 · DOI 10.1016/s2468-2667(19)30075-1 -
Telemonitoring-Supported Exercise Training in Employees With Metabolic Syndrome Improves Liver Inflammation and Fibrosis.
Haufe S, Hupa-Breier KL, Bayerle P, Boeck HT, et al · · 2021 · cited 10× · PMID 34140456 · DOI 10.14309/ctg.0000000000000371 -
Employers With Metabolic Syndrome and Increased Depression/Anxiety Severity Profit Most From Structured Exercise Intervention for Work Ability and Quality of Life.
Haufe S, Kahl KG, Kerling A, Protte G, et al · · 2020 · cited 10× · PMID 32625123 · DOI 10.3389/fpsyt.2020.00562 -
The Impact of Body Weight Changes versus Exercise Capacity Changes on Health-Related Factors following a Lifestyle Intervention in Employees with Metabolic Syndrome.
Bayerle P, Haufe S, Kück M, Protte G, et al · · 2022 · cited 4× · PMID 36364823 · DOI 10.3390/nu14214560
Verify or expand the search:
- PubMed search for NCT03293264
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Exercise training group
Trials testing the same drug.
- NCT05966805 — Impact of Exercise Intervention on Well-being in Shift-working Acute Care Nurses · NA · completed
- NCT05078749 — The Effects of Telerehabilitation Based Exercise Program in Patients With Systemic Sclerosis · NA · unknown
- NCT04972864 — Effects of Respiratory Muscle Training in Patients With Post COVID-19 · NA · completed
- NCT03625063 — Effects of Pulmonary Rehabilitation in Hematopoietic Stem Cell Transplantation Recipients · NA · completed
Other recruiting trials for Metabolic Syndrome
Currently open trials in the same condition.
- NCT07501858 — Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metaboli · recruiting
- NCT06857929 — "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" · NA · recruiting
- NCT07237750 — iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss · NA · recruiting
- NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
- NCT07383220 — Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure · NA · recruiting
Other Hannover Medical School trials
Trials by the same sponsor.
- NCT07384039 — Exercise Training in Patients With Myeloproliferative Neoplasms · NA · not yet recruiting
- NCT06740747 — Intermittent Theta-Burst Stimulation to Improve Negative Symptoms and Cognition in Schizophrenia · NA · recruiting
- NCT06795516 — Observational Study on the Clinical Use of ex Vivo Lung Perfusion (XPS™) for Lung Transplantation · terminated
- NCT06603311 — Finite Treatment of Hepatitis Delta With Bulevirtide: Identification of Biomarkers Associated With Sustained Control of · NA · active not recruiting
- NCT06493006 — Promoting Sustainable and Active Mobility Among Employees and Students · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03293264 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hannover Medical School
- Last refreshed: 29 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03293264.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing